HelloMD, a leading online cannabis telehealth company has announced expansion of its white-label services for Licensed Producers and brick-and-mortar clinics, to better serve the Canadian medical cannabis market.
The company’s white-labeled patient consult and support services offer Licensed Producers and brick-and-mortar cannabis clinics an opportunity to rapidly expand their patient populations while adding online solutions to better serve the fast growing wellness-oriented cannabis consumer segment.
Many Canadians seeking medical cannabis have physical limitations, live in areas far from the nearest clinic, or simply prefer the discretion and convenience implicit in virtual consults. HelloMD partners can offer their patients branded, online access to healthcare professionals from the comfort of their preferred location, seven days a week. The HelloMD platform has conducted more than 100,000 online medical cannabis consults and been deployed by 100’s of partners.
With zero capital outlay, and in as little as one day, HelloMD white-label partners can launch branded versions of one or more turnkey services:
100% Online Doctor Consultations. HelloMD partner patients experience the convenience and privacy of talking to a licensed practitioner from the comfort of wherever they choose, and interact in an online environment that reflects the partner’s brand. All practitioners are recruited, trained and managed by HelloMD. Patient documents are securely shared with partners via API or accessed via a partner portal.
Education & Registration Services. Following the online consultation, a patient can engage, via video-chat, with a HelloMD patient services team member for help with licensed producer selection and registration. Alternatively, the partner can choose to have the patient returned to them immediately following the practitioner consult.
Content Solutions. HelloMD can produce ongoing, tailored educational content and make it available within the partner’s branded patient portal. For partners reaching first-time patients, this is an opportunity to extend their position as a trusted source, without the heavy lifting of content creation and management.
The Flowr Corporation (“Flowr”) (TSXV: FLWR) recently launched HelloMD’s turnkey set of telehealth services. Patients and those seeking a medical consultation can access the HelloMD service through Flowr’s website https://flowr.ca/hellomd/.
“Flowr's partnership with HelloMD is part of our plan to offer a premium service and product experience to our medical clients. Flowr believes in easy access to cannabis for those who can benefit from its medicinal qualities and making the HelloMD platform available through our website gives clients convenient, discreet access to healthcare professionals at the time and place of their choosing. For some clients, this may be their only option to access medical cannabis,” said Dr. Lyle Oberg, Flowr Chief Policy and Medical Officer.
“HelloMD has always been a highly partner-centric company. We focus our feature development, service scalability and level of customer service on patients and the partners that serve them. We’re excited to be working on Flowr and others seeking to expand on their reach or the level of service they offer prospective patients,” said Larry Lisser, HelloMD’s SVP of Business Development.
To become a white label partner with HelloMD, please contact Larry Lisser, SVP of Business Development HelloMD, firstname.lastname@example.org
For Media Inquiries:
HelloMD: Garrett Repski, Project Manager, Marigold Marketing & PR, 1-310-351-2383, email@example.com
HelloMD is one of the largest online communities of medical cannabis patients and experts, offering today's cannabis patient a discreet, turnkey experience. At HelloMD.com medical cannabis consumers can consult with a doctor via real-time video, and obtain answers to questions from a network of doctors and experts. Patients can also read the latest in cannabis research and news, and engage with other patients about their experience. For more information about HelloMD, or to join its growing member community, visit www.hellomd.com or follow us on Facebook (@HelloMDcompany) and Twitter (@HelloMD_com)
This press release includes forward-looking information within the meaning of Canadian securities laws, regarding Flowr and its business, which may include, but is not limited to: Flowr’s belief that all clients should have access to products they want and need; the HelloMD program being a part of Flowr’s plans to offer a premium service and experience; beliefs in easy access to cannabis; the HelloMD platform giving clients convenient, discreet access to healthcare professionals; HelloMD helping Flowr expand its reach or level of service to patients or prospective patients; statements relating to the partnership between Flowr and HelloMD; Flowr’s ability to bring premium, quality products to the market; and other factors. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “is expected”, “expects”, “scheduled”, “intends”, “contemplates”, “anticipates”, “believes”, “proposes” or variations (including negative and grammatical variations) of such words and phrases, or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such statements are based on the current expectations of Flowr’s management and are based on assumptions and subject to risks and uncertainties. Although Flowr’s management believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this press release may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting Flowr including risks relating to: Flowr requiring additional financing from time to time in order to continue its operations and such financing being available when needed or on terms and conditions acceptable to Flowr; new laws or regulations adversely affecting Flowr’s business and results of operations; results of operation activities and development of projects, project cost overruns or unanticipated costs and expenses; the partnership with HelloMD not being successful; the inability of Flowr’s products to be consistent, convenient and/or high quality; the inability of Flowr to produce and distribute premium, high quality and/or simple products; the inability of HelloMD to assist Flowr in achieving a high level of patient satisfaction; HelloMD not complying with laws, including privacy laws; the HelloMD partnership not differentiating Flowr’s cannabis offering and making a meaningful difference in patients’ lives; the inability of HelloMD to give patients the access expected from this partnership; the partnership with HelloMD not expanding Flowr’s reach or level of service it offers to patients or prospective patients; Flowr’s sales program failing to provide and deliver premium products, convenience and support; the inability of the HelloMD partnership to offer a premium service and experience and thus affecting Flowr’s sales strategy and sales; the inability to supply the products described herein or any delay in such supply; Flowr’s securities; the inability to generate cash flows, revenues and/or stable margins; the inability to grow organically; risks associated with the geographic markets in which Flowr operates and/or distributes its products; risks associated with fluctuations in exchange rates (including, without limitation, fluctuations in currencies); risks associated with the use of Flowr’s products to treat certain conditions; the cannabis industry and the regulation thereof; failure to comply with applicable laws; risks relating to partnership arrangements and possible failure to realize the anticipated benefits of partnership arrangements, including those discussed herein; product launches (including, without limitation, unsuccessful product launches) or the inability to launch products; the failure to obtain regulatory approvals; economic factors, market conditions, risks associated with the acquisition and/or launch of products and the equity and debt markets generally; risks associated with growth and competition (including, without limitation, with respect to Flowr’s products); general economic and stock market conditions; risks and uncertainties detailed from time to time in Flowr’s filings with the Canadian Securities Administrators; and many other factors beyond the control of Flowr. Although Flowr has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking information can be guaranteed. Except as required by applicable securities laws, forward-looking information speaks only as of the date on which it is made and Flowr undertakes no obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events, or otherwise.